American Journal of Kidney Diseases
Volume 53, Issue 3, Supplement 2 , Pages S1-S2, March 2009

Tables

Article Outline

     


    Table 1.Recommended Parameters and Frequency of Nutritional Assessment for Children with CKD Stages 2 to 5 and 5D S16

    Table 2.Equations to Estimate Energy Requirements for Children at Healthy Weights S36

    Table 3.Equations to Estimate Energy Requirements for Children Ages 3 to 18 Years Who Are Overweight S36

    Table 4.Physical Activity Coefficients for Determination of Energy Requirements in Children Ages 3 to 18 Years S37

    Table 5.Nutrient Content or Infusion Rates of IDPN Reported From Small Pediatric Cohorts S41

    Table 6.Potential Adverse Occurrences with IDPN S41

    Table 7.Acceptable Macronutrient Distribution Ranges S43

    Table 8.Additional Recommendations on Specific Types of Fat and Carbohydrate S43

    Table 9.Dietary Treatment Recommendations for Children with Dyslipidemia and CKD Stages 5, 5D, and Kidney Transplant S44

    Table 10.Tips to Implement AHA Pediatric Dietary Guidelines for Prevention or Treatment of Dyslipidemia and CVD in Prepubertal Children S44

    Table 11.Dietary Modifications to Lower Serum Cholesterol and Triglycerides for Adolescents with CKD S45

    Table 12.Recommended Dietary Protein Intake in Children with CKD Stages 3 to 5 and 5D S49

    Table 13.Average Ratio of Phosphorus to Protein Content in Various Protein-Rich Foods S51

    Table 14.Dietary Reference Intake: Recommended Dietary Allowance and Adequate Intake S54

    Table 15.Physiological Effects and Sources of Vitamins S55

    Table 16.Physiological Effects and Sources of Trace Elements S56

    Table 17.Dietary Reference Intakes: Tolerable Upper Intake Levels S56

    Table 18.Multivitamin Comparisons S57

    Table 19.Medicines and Other Substances Interfering with Vitamin B6 and Folic Acid Metabolism That May Contribute to Vitamin Deficiency S57

    Table 20.Recommended Calcium Intake for Children with CKD Stages 2 to 5 and 5D S61

    Table 21.Calcium Content of Common Calcium-Based Binders or Supplements S62

    Table 22.Recommended Supplementation for Vitamin D Deficiency/Insufficiency in Children with CKD S65

    Table 23.Recommended Maximum Oral and/or Enteral Phosphorus Intake for Children with CKD S67

    Table 24.Target Range of Serum PTH by Stage of CKD S67

    Table 25.Age-Specific Normal Ranges of Blood Ionized Calcium, TotalCalcium and Phosphorus S67

    Table 26.DRI for Healthy Children for Water, Sodium, Chloride and Potassium S71

    Table 27.Insensible Fluid Losses S73

    Table 28.Normal Serum Carnitine Levels (μmol/L) S75

    Table 29.Nutrition-Related Side-Effects of Immunosuppressive Medications S78

    Table 30.Recommended Frequency of Measurement of Calcium, Phosphorus, PTH and Total CO2 After Transplant S81

    Table 31.General Food Safety Recommendations for Immunosuppressed Children S82

    Table 32.Resources for Calculating Anthropometric SDS and Percentiles S86

    Table 33.Resources for Calculating Midparental Height S86

    Table 34.Resources for Calculating Estimated Energy Requirements S86

    Table 35.Actual and Adjusted Amounts and Ratios of Phosphorus to Protein in Specific Foods S87

    Table 36.Nutrient Content of Feeds and Supplements Used in Children with CKD S88

    Table 37.Nutrient Content of Selected Foods High in Fiber S90

    Table 38.Suggested Rates for Initiating and Advancing Tube Feedings S91

    Table 39.KDIGO Nomenclature and Description for Rating Guideline Recommendations S102

    Table 40.Checklist for Guideline Reporting for the Update of the KDOQI Pediatric Nutrition Guideline S102

PII: S0272-6386(08)01733-2

doi:10.1053/j.ajkd.2008.12.004

American Journal of Kidney Diseases
Volume 53, Issue 3, Supplement 2 , Pages S1-S2, March 2009